Bal Pharma Ltd Nine Monthly Results

Gross Sales

221.21

244.59

221.77

145.15

179.72

Excise Duty

0

0

0

0

0

Net Sales

221.21

244.59

221.77

145.15

179.72

Other Operating Income

0

0

0

0

0

Other Income

1.12

0.39

0.75

0.29

0.41

Total Income

222.33

244.99

222.52

145.44

180.13

Total Expenditure

199.29

222.66

204.81

134.34

161.61

PBIDT

23.04

22.33

17.71

11.1

18.52

Interest

12.9

11.12

8.33

5.22

8.86

PBDT

10.13

11.21

9.38

5.88

9.66

Depreciation

7.59

7.92

7.04

4.59

6.08

Minority Interest Before NP

0

0

0

0

0

Tax

1.16

2.18

2.75

1.97

2.39

Deferred Tax

-0.44

-0.8

-1.41

-1.1

0

Reported Profit After Tax

1.82

1.91

1

0.41

1.18

Minority Interest After NP

0.04

-0.01

0.03

0.01

0.02

Net Profit after Minority Interest

1.78

1.92

0.97

0.4

1.16

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

1.78

1.92

0.97

0.4

1.16

EPS (Unit Curr.)

1.14

1.21

0.64

0.26

0.82

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

15.92

15.8

15.69

14.17

14.17

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

10.41

9.12

7.98

7.64

10.3

PBDTM(%)

4.57

4.58

4.22

4.05

5.37

PATM(%)

0.82

0.78

0.45

0.28

0.65